Taina Turpeenniemi-Hujanen
Overview
Explore the profile of Taina Turpeenniemi-Hujanen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
95
Citations
1935
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kotkaranta P, Chan M, Vuolio T, Miinalainen I, Kuitunen H, Turpeenniemi-Hujanen T, et al.
Biomed Pharmacother
. 2024 Dec;
182():117785.
PMID: 39721323
It has been demonstrated that diffuse large B-cell lymphoma (DLBCL) is especially sensitive to ferroptosis. Currently, confirming the presence of ferroptosis requires flow cytometry, which is a time consuming and...
2.
Joensuu H, Fraser J, Wildiers H, Huovinen R, Auvinen P, Utriainen M, et al.
JAMA Netw Open
. 2024 Aug;
7(8):e2429772.
PMID: 39186271
Importance: The standard adjuvant treatment for patients with ERRB2-positive breast cancer is chemotherapy plus 1 year of trastuzumab. Shorter durations of trastuzumab administration improve cardiac safety, but more information is...
3.
Ollikainen R, Sippola A, Turpeenniemi-Hujanen T, Kuitunen H, Porvari K, Haapasaari K, et al.
Anticancer Res
. 2024 Jul;
44(8):3255-3259.
PMID: 39060054
Background/aim: Central nervous system (CNS) involvement in aggressive B-cell lymphoma, either as a primary or secondary event to systemic disease, portends a poor prognosis. This study sought to identify patients...
4.
Lehto U, Ojanen M, Laaperi S, Kohonen M, Harkanen T, Honkalampi K, et al.
Int J Behav Med
. 2024 Jun;
PMID: 38918279
Background: Social relationships are important health resources and may be investigated as social networks. We measured cancer patients' social subnetworks divided into generic social networks (people known to the patients)...
5.
Rajamaki A, Sorigue M, Prusila R, Kuusisto M, Kuitunen H, Jantunen E, et al.
Acta Oncol
. 2024 May;
63:267-272.
PMID: 38709114
Background: The modern-day therapeutic landscape for follicular lymphoma (FL) includes a number of highly effective therapies. Patients And Methods: We set out to determine progression-free survival (PFS) after front line,...
6.
Kaprio E, Prusila R, Tokola S, Kuusisto M, Jantunen E, Kuitunen H, et al.
Cancer Med
. 2024 Jan;
13(1):e6898.
PMID: 38164067
Background: Rituximab-based combinations are the standard of care in diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL). Despite being on market for over 20 years, some of the adverse...
7.
Puhakka I, Kuitunen H, Jakala P, Sonkajarvi E, Turpeenniemi-Hujanen T, Ronka A, et al.
BMC Cancer
. 2022 Mar;
22(1):236.
PMID: 35241020
Background: We report here the first population-based incidence rates and prognosis of primary central nervous system lymphoma (PCNSL) in Finland. Methods: Finnish Cancer Registry data by histological diagnosis and tumor...
8.
Kiiskila J, Uotila P, Haapasaari K, Kauppila S, Teppo H, Kuusisto M, et al.
Hum Pathol
. 2021 Aug;
117:79-87.
PMID: 34364921
Follicular T-cell lymphoma (FTCL) is a rare subtype of mature T-cell lymphoma. It was recently recognized as a separate lymphoma entity in the 2017 revised fourth edition of the World...
9.
Ollikainen R, Kotkaranta P, Kemppainen J, Teppo H, Kuitunen H, Pirinen R, et al.
Leuk Lymphoma
. 2021 Apr;
62(9):2151-2160.
PMID: 33856274
Although treatment for diffuse large B-cell lymphoma (DLBCL) has taken some notable steps in the 2000s, there are still subgroups of patients suffering from high mortality and relapse rates. To...
10.
Tokola S, Kuitunen H, Turpeenniemi-Hujanen T, Kuittinen O
Cancer Med
. 2021 Apr;
10(9):3035-3044.
PMID: 33792190
The application of positron emission tomography (PET)-computed tomography (CT) in treatment response evaluation has increased in diffuse large B-cell lymphoma (DLBCL), although its predictive value is controversial. We retrospectively analyzed...